A Synergistic Interaction Between Lapatinib and Chemotherapy Agents in a Panel of Cell Lines Is Due to the Inhibition of the Efflux Pump BCRP
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-10-0197
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2010
Authors
Publisher
American Association for Cancer Research (AACR)